Compare DXPE & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DXPE | AXGN |
|---|---|---|
| Founded | 1908 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 1998 | 2013 |
| Metric | DXPE | AXGN |
|---|---|---|
| Price | $181.22 | $37.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $200.00 | $53.82 |
| AVG Volume (30 Days) | 108.1K | ★ 1.3M |
| Earning Date | 11-05-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.25 | N/A |
| EPS | ★ 2.98 | N/A |
| Revenue | ★ $1,247,043,000.00 | $225,208,000.00 |
| Revenue This Year | $12.53 | $26.83 |
| Revenue Next Year | $8.07 | $28.58 |
| P/E Ratio | $60.93 | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $84.04 | $15.27 |
| 52 Week High | $208.00 | $52.91 |
| Indicator | DXPE | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 44.74 | 31.82 |
| Support Level | $179.71 | $29.80 |
| Resistance Level | $186.93 | $44.83 |
| Average True Range (ATR) | 6.49 | 1.50 |
| MACD | -1.14 | -0.48 |
| Stochastic Oscillator | 16.68 | 18.19 |
DXP Enterprises Inc is engaged in the business of distributing maintenance, repair and operating (MRO) products, equipment and service to customers in various end markets, including general industrial, energy, food & beverage, chemical, transportation, water and wastewater. The company operates through three business segments: Service Centers, Innovative Pumping Solutions and Supply Chain Services. The majority of revenue is derived from the Service Centers segment, which provides a wide range of MRO products in the rotating equipment, bearing, power transmission, hose, fluid power, metal working, fastener, industrial supply, safety products and safety services categories. Geographically, it generates the maximum revenue from the United States.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.